Market Overview:
The global clot management device market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, technological advancements in clot management devices, and rising demand for minimally invasive procedures. In terms of type, the inferior vena cava filters (IVCF) segment is expected to account for the largest share of the global clot management device market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to the increasing use of IVCFs for prophylaxis and treatment of venous thromboembolism (VTE).
Product Definition:
A clot management device is a medical tool that is used to remove blood clots from the body. The device may be inserted into a vein or artery to break up the clot, or it may be used to suction the clot out of the body. Clot management devices are often used in cases of heart attack, stroke, and deep vein thrombosis.
Inferior Vena Cava Filters(IVCF):
Inferior vena cava filters (IVCF) are used for the removal of blood from the lower part of the digestive system. It is a small flexible tube that is inserted into a vein through which it can drain blood from the stomach, intestine or liver to an outside collection bag. IVCF has high demand in hospitals and clinics owing to its use in treating conditions such as acute abdominal pain, biliary tract disease, pancreatitis or hepatic encephalopathy.
Neurovascular Embolectomy Devices:
Neurovascular embolectomy devices are used for the treatment of aneurysms, cerebral arteriovenous malformations (AVM), dural arteriovenous fistula (DAVF) and other abnormal dural blood vessels. Neurovascular embolectomy is a surgical procedure wherein the diseased or damaged part of brain is removed and replaced with an artificial device to re-organize its functioning.
Application Insights:
Based on application, the global clot management device market is segmented into hospitals, ambulatory surgical centers (ASCs), diagnostic centers and others. The hospital segment dominated the market in 2017 owing to factors such as a high prevalence of chronic diseases that require frequent medical visits. Moreover, an increase in healthcare spending and government initiatives to promote better hygiene in hospitals are expected to boost demand for clot management devices during this period.
The ASC segment is anticipated to witness lucrative growth over the forecast period due primarily to increasing awareness about advanced treatments for various conditions among patients across the globe. In addition, rising incidences of stroke and blood clots are driving demand for these devices at ASCs which will further propel growth during this period. According Clot Management Services Market Size & Trend Report by TTI International Inc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of advanced technologies for clot management. Moreover, increasing incidence of stroke and heart attacks is also expected to drive growth during the forecast period. Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure & reimbursement policies along with rising patient awareness levels regarding available treatment options for stroke/heart attack care.
Major players operating in this space include Abbott; Baxter; BMS; CCS Medical Systems; Medtronic plc.; Stryker Corporation.; Terumo Medical Corporation.; Unilife Corporation.
Growth Factors:
- Increasing incidence of clot-related disorders such as deep vein thrombosis and pulmonary embolism
- Growing demand for minimally invasive procedures for clot management
- Rising awareness about the benefits of using clot management devices
- Technological advancements in clot management devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Clot Management Device Market Research Report
By Type
Inferior Vena Cava Filters(IVCF), Neurovascular Embolectomy Devices, Catheter-Directed Thrombolysis(CDT) Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters/Clot Management Catheter
By Application
Hospitals, Ambulatory Surgical Center, Diagnostic Center
By Companies
Edwards Lifesciences, Boston Scientific, AngioDynamics, Cook, Acandis, Stryker, Covidien(Medtronic), Argon, Asid Bonz, DePuy Synthes, Edwards Lifesciences, Dispomedica, IVascular, Eurocor, Teleflex, LeMaitre Vascular, Phenox, Merit Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Clot Management Device Market Report Segments:
The global Clot Management Device market is segmented on the basis of:
Types
Inferior Vena Cava Filters(IVCF), Neurovascular Embolectomy Devices, Catheter-Directed Thrombolysis(CDT) Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters/Clot Management Catheter
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Center, Diagnostic Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Edwards Lifesciences
- Boston Scientific
- AngioDynamics
- Cook
- Acandis
- Stryker
- Covidien(Medtronic)
- Argon
- Asid Bonz
- DePuy Synthes
- Edwards Lifesciences
- Dispomedica
- IVascular
- Eurocor
- Teleflex
- LeMaitre Vascular
- Phenox
- Merit Medical
Highlights of The Clot Management Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inferior Vena Cava Filters(IVCF)
- Neurovascular Embolectomy Devices
- Catheter-Directed Thrombolysis(CDT) Devices
- Percutaneous Thrombectomy Devices
- Embolectomy Balloon Catheters/Clot Management Catheter
- By Application:
- Hospitals
- Ambulatory Surgical Center
- Diagnostic Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clot Management Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A clot management device is a medical device that helps to reduce the risk of blood clots. This can be done by helping to break up the clots, or by removing them from the body.
Some of the major players in the clot management device market are Edwards Lifesciences, Boston Scientific, AngioDynamics, Cook, Acandis, Stryker, Covidien(Medtronic), Argon, Asid Bonz, DePuy Synthes, Edwards Lifesciences, Dispomedica, IVascular, Eurocor, Teleflex, LeMaitre Vascular, Phenox, Merit Medical.
The clot management device market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clot Management Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clot Management Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clot Management Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clot Management Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clot Management Device Market Size & Forecast, 2020-2028
4.5.1 Clot Management Device Market Size and Y-o-Y Growth
4.5.2 Clot Management Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Inferior Vena Cava Filters(IVCF)
5.2.2 Neurovascular Embolectomy Devices
5.2.3 Catheter-Directed Thrombolysis(CDT) Devices
5.2.4 Percutaneous Thrombectomy Devices
5.2.5 Embolectomy Balloon Catheters/Clot Management Catheter
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Center
6.2.3 Diagnostic Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clot Management Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clot Management Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Inferior Vena Cava Filters(IVCF)
9.6.2 Neurovascular Embolectomy Devices
9.6.3 Catheter-Directed Thrombolysis(CDT) Devices
9.6.4 Percutaneous Thrombectomy Devices
9.6.5 Embolectomy Balloon Catheters/Clot Management Catheter
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Center
9.10.3 Diagnostic Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Inferior Vena Cava Filters(IVCF)
10.6.2 Neurovascular Embolectomy Devices
10.6.3 Catheter-Directed Thrombolysis(CDT) Devices
10.6.4 Percutaneous Thrombectomy Devices
10.6.5 Embolectomy Balloon Catheters/Clot Management Catheter
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Center
10.10.3 Diagnostic Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Inferior Vena Cava Filters(IVCF)
11.6.2 Neurovascular Embolectomy Devices
11.6.3 Catheter-Directed Thrombolysis(CDT) Devices
11.6.4 Percutaneous Thrombectomy Devices
11.6.5 Embolectomy Balloon Catheters/Clot Management Catheter
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Center
11.10.3 Diagnostic Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Inferior Vena Cava Filters(IVCF)
12.6.2 Neurovascular Embolectomy Devices
12.6.3 Catheter-Directed Thrombolysis(CDT) Devices
12.6.4 Percutaneous Thrombectomy Devices
12.6.5 Embolectomy Balloon Catheters/Clot Management Catheter
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Center
12.10.3 Diagnostic Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Inferior Vena Cava Filters(IVCF)
13.6.2 Neurovascular Embolectomy Devices
13.6.3 Catheter-Directed Thrombolysis(CDT) Devices
13.6.4 Percutaneous Thrombectomy Devices
13.6.5 Embolectomy Balloon Catheters/Clot Management Catheter
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Center
13.10.3 Diagnostic Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clot Management Device Market: Competitive Dashboard
14.2 Global Clot Management Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Edwards Lifesciences
14.3.2 Boston Scientific
14.3.3 AngioDynamics
14.3.4 Cook
14.3.5 Acandis
14.3.6 Stryker
14.3.7 Covidien(Medtronic)
14.3.8 Argon
14.3.9 Asid Bonz
14.3.10 DePuy Synthes
14.3.11 Edwards Lifesciences
14.3.12 Dispomedica
14.3.13 IVascular
14.3.14 Eurocor
14.3.15 Teleflex
14.3.16 LeMaitre Vascular
14.3.17 Phenox
14.3.18 Merit Medical
